The Part D Drug Cap Climbs to $2,400 and the Deductible to $700

Image Credit: Harrison Keely – CC BY 4.0/Wiki Commons

Medicare’s annual limit on out-of-pocket spending for covered prescription drugs will rise from $2,100 in 2026 to $2,400 in 2027, and the highest deductible a Part D plan may charge will climb from $615 to $700. Both figures are now final and appear in federal Medicare documents as plans finish publishing their 2027 terms.

The increases come from a formula in federal law that adjusts the amounts each year based on growth in Part D drug spending. They matter most to people taking expensive brand-name medications, the beneficiaries most likely to reach the cap, and they take effect January 1 for anyone enrolled in a Medicare drug plan or a Medicare Advantage plan with drug coverage.

How the 2027 Numbers Were Set

The Centers for Medicare & Medicaid Services published the figures in its calendar year 2027 Rate Announcement on April 6, 2026. Its table of updated benefit parameters lists the standard Part D deductible at $700 for 2027, up from $615, and the out-of-pocket threshold at $2,400, up from $2,100. CMS said it calculated both by multiplying the 2026 amounts by the 2027 annual percentage increase and rounding as the statute requires. The same table puts that annual percentage increase at 13.65%.

Medicare’s Part D cost page now lists the 2027 amounts alongside the current rules. For 2026, it says enrollees in the standard benefit pay 25% of the cost of generic and brand-name drugs until out-of-pocket spending on covered Part D drugs reaches $2,100. After that, catastrophic coverage begins automatically and the enrollee pays nothing out of pocket for covered Part D drugs for the rest of the calendar year.

For someone whose covered prescriptions are expensive enough to reach the limit, the most that person can pay out of pocket for covered Part D drugs in 2027 is $2,400. That is $300 more than the 2026 maximum.


Tracking spending against the cap: A section on the new Part D out-of-pocket cap and a medication and cost tracker support logging what each prescription fill costs over the year and checking how close spending sits to the limit. Both are part of The Medicare Cost & Coverage Protection Kit.

What Counts Toward the Limit

The cap applies to out-of-pocket spending on covered Part D drugs. Medicare says that spending includes certain payments made on an enrollee’s behalf, such as payments through the Extra Help program. A drug a plan does not cover sits outside that calculation, which is why a plan’s drug list matters as much as the cap itself.

The $700 figure is a ceiling, not a requirement. Medicare’s cost page says each plan sets its own deductible, no plan may exceed the federal maximum, and some plans charge no deductible at all. Two plans with similar premiums can therefore produce very different bills in January and February, when the deductible is being met.

For people with full Extra Help who also have full Medicaid benefits, the 2027 parameters keep the Part D deductible at $0, according to the same CMS table.

Premiums Are Shifting Too

On September 28, CMS projected that the average total monthly premium for stand-alone Part D plans will rise by less than a dollar, from $35.09 in 2026 to $36 in 2027. Those are averages; individual plan premiums vary by plan and region.

In a July fact sheet on plan bids, CMS set the 2027 Part D base beneficiary premium at $41.33. The agency also said it is ending the Part D Premium Stabilization Demonstration after 2026, returning the program to traditional market conditions in 2027.

Spreading Costs Does Not Shrink Them

The Medicare Prescription Payment Plan lets an enrollee spread out-of-pocket drug costs across the calendar year instead of paying them at the pharmacy counter. Medicare states plainly that the program does not save money or lower drug costs. It changes the timing of the bill, which can matter for someone who would otherwise meet the deductible and reach the cap in the first few months of the year.

Extra Help works differently. It lowers what eligible people with limited income and resources pay for premiums, deductibles and prescriptions, and the 2027 CMS tables set its copayment levels separately from the standard benefit.

Checking Plans Before December 7

Medicare’s Open Enrollment Period runs from October 15 through December 7, with new coverage starting January 1. That is the main window to move to a drug plan with a lower deductible, a better list of covered drugs or a more convenient pharmacy network.

The costliest mistake is assuming a current plan will treat the same prescriptions the same way next year. A drug can move to a different cost tier or come off a plan’s list entirely, and the higher 2027 deductible ceiling gives plans room to charge more before coverage starts. Each plan’s Annual Notice of Change spells out what is different for 2027, and comparing the full list of medications against each plan’s terms is the way to see the real cost.


Where the higher ceiling leaves a gap

The 2027 figures raise the ceiling, but they do not show when a particular enrollee will hit it, or how much of the deductible and cap will land in the first months of the year. That timing depends on each person’s own prescriptions and plan, and it becomes hard to follow once pharmacy receipts and plan statements start arriving.

The Medicare Cost & Coverage Protection Kit covers the new Part D out-of-pocket cap and includes 51 state Medicare cost-help packs, so drug spending can be recorded against the limit and state help with costs can be looked up in one place.

Open the medication and cost tracker in The Medicare Cost & Coverage Protection Kit.

This article was created with AI assistance and reviewed for accuracy against official government sources.